Filling the need for trusted information on national health issues…

Drug Resistance

  • Your Selections:

Refine Results

date

Tags

CDC Blog Posts Discuss Issues Surrounding TB, MDR-TB

CDC’s “Our Global Voices”: A Consequence of Conflict: The Spread of Multidrug-Resistant Tuberculosis Nadine Sunderland of the CDC discusses issues surrounding multidrug-resistant tuberculosis (MDR-TB) in Somalia, including preventing, diagnosing, and treating the disease (3/23). CDC’s “Our Global Voices”: An Ounce of Prevention: Why we must strengthen basic TB control to…

U.K. Establishes $289.5M Fund To Combat Antibiotic-Resistant Infections Worldwide

Financial Times: Budget 2015: Fleming Fund to fight drug-resistant infections “[British Chancellor of the Exchequer] George Osborne announced the creation of a £195m [$289.5 million] fund to fight drug-resistant infections worldwide, with contributions from the government, the Wellcome Trust, and other international charities. The Fleming Fund is being set up…

Third Blog Post In Series Examines China’s History Of Artemisinin Drug Development

Council on Foreign Relation’s “Asia Unbound”: Artemisinin’s Rocky Road to Globalization: Part III In part three of his series on anti-malarial artemisinin drugs, Yanzhong Huang, CFR senior fellow for global health, explores China’s efforts to increase its market share of artemisinin-based combination therapies worldwide. “…To sum up, China has come…

Second Blog Post In Series Examines China’s History Of Artemisinin Drug Development

Council on Foreign Relation’s “Asia Unbound”: Artemisinin’s Rocky Road to Globalization: Part II In part two of his series on anti-malarial artemisinin drugs, Yanzhong Huang, CFR senior fellow for global health, explores the challenges China faced in marketing its artemisinin-based combination therapies worldwide. “…The 2004-2006 artemisinin bubble nevertheless has not…

IBT Examines Strategies Aimed At Promoting Antibiotic Drug Development

International Business Times: Antibiotic Resistance: Why Aren’t Drug Companies Developing New Medicines To Stop Superbugs? “…[A]s many as 10 million people a year could die from antibiotic-resistant bacteria worldwide by 2050 if new treatments are not discovered, according to a recent report from the Review on Antimicrobial Resistance. … Despite…

First Blog Post In Series Examines History Of Artemisinin Development

Council on Foreign Relations’ “Asia Unbound”: Artemisinin’s Rocky Road to Globalization: Part I Yanzhong Huang, CFR senior fellow for global health, examines the history of artemisinin drug development in China during the Cold War era. “…It would take another two decades before [artemisinin-combination therapies (ACTs)] were officially adopted by the…

Artemisinin-Resistant Malaria More Widespread In Asia Than Previously Thought, Research Shows

News outlets discuss a study and commentary regarding the spread of drug-resistant malaria in Asia published in The Lancet Infectious Diseases. Agence France-Presse: Drug-resistant malaria parasite spreading “Parasites resistant to the frontline malaria drug have spread westward from southeast Asia to just short of the Indian border — a gateway…

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.